Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP674309.RAfL7wduOYMpIyvL2LKntqcDCKAwgGmNfe3R_T7rX2Rps130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP674309.RAfL7wduOYMpIyvL2LKntqcDCKAwgGmNfe3R_T7rX2Rps130_assertion type Assertion NP674309.RAfL7wduOYMpIyvL2LKntqcDCKAwgGmNfe3R_T7rX2Rps130_head.
- NP674309.RAfL7wduOYMpIyvL2LKntqcDCKAwgGmNfe3R_T7rX2Rps130_assertion description "[Particularly, ER?, PR, hMLH1, CDKN2A/P16, SFRP1, SFRP2 and SFRP5 revealed a promoter methylation status in endometrioid carcinoma, whereas SFRP4 showed demethylation in cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP674309.RAfL7wduOYMpIyvL2LKntqcDCKAwgGmNfe3R_T7rX2Rps130_provenance.
- NP674309.RAfL7wduOYMpIyvL2LKntqcDCKAwgGmNfe3R_T7rX2Rps130_assertion evidence source_evidence_literature NP674309.RAfL7wduOYMpIyvL2LKntqcDCKAwgGmNfe3R_T7rX2Rps130_provenance.
- NP674309.RAfL7wduOYMpIyvL2LKntqcDCKAwgGmNfe3R_T7rX2Rps130_assertion SIO_000772 21709441 NP674309.RAfL7wduOYMpIyvL2LKntqcDCKAwgGmNfe3R_T7rX2Rps130_provenance.
- NP674309.RAfL7wduOYMpIyvL2LKntqcDCKAwgGmNfe3R_T7rX2Rps130_assertion wasDerivedFrom befree-20140225 NP674309.RAfL7wduOYMpIyvL2LKntqcDCKAwgGmNfe3R_T7rX2Rps130_provenance.
- NP674309.RAfL7wduOYMpIyvL2LKntqcDCKAwgGmNfe3R_T7rX2Rps130_assertion wasGeneratedBy ECO_0000203 NP674309.RAfL7wduOYMpIyvL2LKntqcDCKAwgGmNfe3R_T7rX2Rps130_provenance.